Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author exact 317DC97E-F0EE-11E1-A9DE-61C894A0A6B4 cql: author exact 11FF69AE-F0EE-11E1-A9DE-61C894A0A6B4

Add to list
- Conference Paper
- C3
RRM2 enhances MYCN driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Lisa Depestel (UGent) , Carolina de Carvalho Nunes (UGent) , Liselot Mus (UGent) , Iris Nelen (UGent) , Louis Delhaye (UGent) , Kaylee Keller, Volodimir Olexiouk, Fanny De Vloed (UGent) , Ellen Sanders (UGent) , Aline Eggermont (UGent) , et al.

(2022) OncoPoint Symposium 2022, Abstracts.
Add to list
- Journal Article
- A1
- open access
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Carolina de Carvalho Nunes (UGent) , Lisa Depestel (UGent) , Liselot Mus (UGent) , Kaylee M. Keller, Louis Delhaye (UGent) , Amber Louwagie (UGent) , Muhammad Rishfi (UGent) , Alex Whale, Neesha Kara, Simon R. Andrews, et al.

(2022) SCIENCE ADVANCES. 8(28).
Add to list
- Conference Paper
- C3
SOX11 as guardian of epigenetic plasticity in neuroblastoma

Bieke Decaesteker (UGent) , Amber Louwagie (UGent) , Siebe Loontiens (UGent) , Sara De Brouwer, Carolina de Carvalho Nunes (UGent) , Geertrui Denecker (UGent) , Fanny De Vloed (UGent) , Lisa Depestel (UGent) , Juliette Roels (UGent) , Karen Verboom, et al.

(2021) Advances in Neuroblastoma Research (ANR 2021), Abstracts.
Add to list
- Conference Paper
- C3
SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma

Amber Louwagie (UGent) , Bieke Decaesteker (UGent) , Carolina de Carvalho Nunes (UGent) , Geertrui Denecker (UGent) , Volodimir Olexiouk (UGent) , Karen Verboom, Moritz Gartlgruber, Wouter Van Loocke (UGent) , Elena Afanasyeva, Pauline Depuydt, et al.

(2019) OncoPoint, 7th Research seminar, Abstracts.
Add to list
- Conference Paper
- C3
SOX11 as mediator of the adrenergic cell state in NB

Bieke Decaesteker (UGent) , Amber Louwagie (UGent) , Sara De Brouwer (UGent) , Volodimir Olexiouk (UGent) , Geertrui Denecker (UGent) , Carolina de Carvalho Nunes (UGent) , Karen Verboom, Moritz Gartlgruber, Wouter Van Loocke (UGent) , Elena Afanasyeva, et al.

(2019) Pediatric Oncology and Hematology, 2nd KiTZ symposium, Abstracts.
Add to list
- Conference Paper
- C3
SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma

Amber Louwagie (UGent) , Bieke Decaesteker (UGent) , Sara De Brouwer (UGent) , Geertrui Denecker (UGent) , Carolina de Carvalho Nunes (UGent) , Volodimir Olexiouk (UGent) , Karen Verboom, Moritz Gartlgruber, Wouter Van Loocke (UGent) , Elena Afanasyeva, et al.

(2019) Belgian Society for Human Genetics, 19th Annual meeting, Abstracts.

Academic Bibliography

RRM2 enhances MYCN driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

SOX11 as guardian of epigenetic plasticity in neuroblastoma

SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma

SOX11 as mediator of the adrenergic cell state in NB

SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma

Contents

Support

Contact